波音游戏-波音娱乐城赌球打不开

Greater Bay Biotechnology

 

Greater Bay Biotechnology focuses on developing innovative microneedles device for drug and cell delivery. Our cryomicroneedles (CMNs) is an innovative device which allows effective storage, transportation, and in situ delivery of living cells, biologics and drug. Applications include diabetes treatment, cell and dermatology therapy.

Greater Bay Biotechnology is founded by researchers from City University of Hong Kong and is supported by CityU HK Tech 300 Seed Fund and The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme. We received multiple accolades for our innovation.

We work in partnership with pharmaceutical companies to develop innovative, minimally invasive and safe drug and cell delivery solutions. This include delivering insulin using our CMNs as a minimally invasive treatment option for the 130 million diabetes patients in China. We also expand the application of microneedles technology in the delivery of other drug, cosmetic and cell formulations.

 

 

Team members

Mr Ng Chelon Colin* (Master, Dept. of Biomedical Sciences, CityU)
Dr Zheng Mengjia (Postdoc, Dept. of Biomedical Engineering, CityU)
Ms Zhang Yuyue (PhD, Dept. of Biomedical Engineering, CityU)
Ms Zhang Jitian (PhD, Dept. of Biomedical Sciences, CityU)

* Person-in-charge
(Info based on the team's application form)

Achievement(s)
  1. CityU HK Tech 300 Seed Fund (2021)
  2. The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme
  3. Second runner-up, Hong Kong Chapter of “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021
  4. Silver Prize, The 7th China International College Students’ “Internet+” Innovation and Entrepreneurship Competition
  5. Second prize, The 4th "Beijing-Hong Kong Youth Innovation and Entrepreneur Cup" Entrepreneurship Competition
  6. Third Prize, 2022 Chengdu "Rongpiao Cup" High-level Talents Innovation and Entrepreneurship Competition (Shuangliu District and Guangdong-Hong Kong-Macao Greater Bay Area Competition)
  7. Third prize, 2021 “創匯香湘" Innovation and Entrepreneurship Competition
  8. Selected to be in the Ministry of Industry and Information Technology (MIIT) First "Light of Innovation" SME technological innovation outstanding achievement list  (the only selected enterprise in Hong Kong, Macao and Taiwan)
  9. Selected to be as The 4th Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Innovative Biotechnology Enterprises

 


大发888游戏平台3403| 百家乐投法| 大发888娱乐场888| 百家乐算牌e世博| 百家乐官网平台哪个比较安全| 百家乐官网类游戏平台| 赌博百家乐官网游戏| 缅甸百家乐官网赌场| 赌博百家乐经验| 全讯网开奖直播| 德州扑克哪个平台好| 百家乐官网代理加盟| 百家乐官网最佳注码法| 玩百家乐官网去哪个娱乐城最安全| 百家乐下注稳赢法| 澳门百家乐赌客| 百家乐一黑到底| 网络百家乐赚| 六合彩报码室| 皇冠足球投注网| 百家乐官网视频游戏网站| 狮威百家乐官网赌场娱乐网规则 | 大发888客户端安装| 如皋市| 财神百家乐官网娱乐城| 澳门百家乐官网游戏说明| 百家乐官网记牌器| 百家乐闲单开多少| 大发888娱乐场下载com| 网上玩百家乐官网犯法| 百家乐庄闲机率| 利高百家乐的玩法技巧和规则 | 顶级赌场连环夺宝ios下载| 百家乐官网游戏玩法技巧| 百家乐官网mediacorp| 赌场百家乐规则| 永利网上娱乐| 富贵乐园棋牌游戏| 百家乐官网娱乐求解答| 真人百家乐| 百家乐官网娱乐城网址|